Rocket PharmaceuticalsRCKT
About: Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
Employees: 299
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
152% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 23
113% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 45
19% more funds holding
Funds holding: 189 [Q3] → 224 (+35) [Q4]
1.41% more ownership
Funds ownership: 101.68% [Q3] → 103.1% (+1.41%) [Q4]
9% less call options, than puts
Call options by funds: $2.09M | Put options by funds: $2.28M
19% less capital invested
Capital invested by funds: $1.71B [Q3] → $1.38B (-$328M) [Q4]
25% less funds holding in top 10
Funds holding in top 10: 4 [Q3] → 3 (-1) [Q4]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Scotiabank Greg Harrison 32% 1-year accuracy 13 / 41 met price target | 743%upside $51 | Sector Outperform Maintained | 12 May 2025 |
Canaccord Genuity Whitney Ijem 30% 1-year accuracy 13 / 43 met price target | 462%upside $34 | Buy Maintained | 12 May 2025 |
Chardan Capital Geulah Livshits 16% 1-year accuracy 11 / 69 met price target | 644%upside $45 | Buy Maintained | 9 May 2025 |
JP Morgan Eric Joseph 41% 1-year accuracy 12 / 29 met price target | 627%upside $44 | Overweight Maintained | 9 May 2025 |
Goldman Sachs Richard Law 45% 1-year accuracy 5 / 11 met price target | 115%upside $13 | Neutral Maintained | 9 May 2025 |
Financial journalist opinion
Based on 3 articles about RCKT published over the past 30 days









